Document Detail

Adrenomedullin increases renal nitric oxide production and ameliorates renal injury in mice with unilateral ureteral obstruction.
MedLine Citation:
PMID:  20172553     Owner:  NLM     Status:  MEDLINE    
PURPOSE: We evaluated the effects of adrenomedullin (Peptide Institute, Minoh-shi, Osaka, Japan) on mediators, including nitric oxide and transforming growth factor-beta, and parameters of renal injury in a murine unilateral ureteral obstruction model. MATERIALS AND METHODS: Three study groups of control, adrenomedullin treated and adrenomedullin plus L-NAME treated BALB/C mice, respectively, underwent left unilateral ureteral obstruction. A 24-hour urine sample was collected to measure urinary NO(2)/NO(3) 1 day before unilateral ureteral obstruction and kidneys were harvested on postoperative day 14. Tubulointerstitial damage markers were evaluated by immunohistochemistry. Tissue transforming growth factor-beta was determined by enzyme-linked immunosorbent assay. Endothelial and inducible nitric oxide synthase immunolocalization was also determined. RESULTS: Urinary NO(2)/NO(3) was significantly higher in the adrenomedullin group than in controls, confirming increased renal nitric oxide production. Immunohistochemistry showed increased endothelial nitric oxide synthase in vascular endothelial cells in the adrenomedullin group but tissue transforming growth factor-beta did not significantly differ in controls vs the adrenomedullin group. Interstitial collagen deposition and fibroblasts in the obstructed kidney were significantly decreased in the adrenomedullin group. The number of leukocytes and apoptotic cells in the obstructed kidney were significantly decreased by adrenomedullin. Renal injury amelioration resulting from adrenomedullin was blunted by the nitric oxide synthase inhibitor L-NAME. CONCLUSIONS: Adrenomedullin increased renal nitric oxide, and suppressed tubular apoptosis, interstitial fibrosis and inflammatory cell infiltration in mice with unilateral ureteral obstruction. The renoprotective peptide adrenomedullin may be useful for that condition.
Keiichi Ito; Hidehiko Yoshii; Takako Asano; Kaori Seta; Yasunori Mizuguchi; Masanori Yamanaka; Shigeki Tokonabe; Masamichi Hayakawa; Tomohiko Asano
Related Documents :
7515613 - The inhibition of the constitutive and inducible nitric oxide synthase isoforms by inda...
20172553 - Adrenomedullin increases renal nitric oxide production and ameliorates renal injury in ...
24411123 - Synthesis and biological evaluation of novel tricyclic oxazine and oxazepine fused quin...
Publication Detail:
Type:  Journal Article     Date:  2010-02-20
Journal Detail:
Title:  The Journal of urology     Volume:  183     ISSN:  1527-3792     ISO Abbreviation:  J. Urol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-19     Completed Date:  2010-04-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376374     Medline TA:  J Urol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1630-5     Citation Subset:  AIM; IM    
Copyright Information:
Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenomedullin / pharmacology*,  therapeutic use*
Kidney Failure / drug therapy*,  etiology,  metabolism*
Mice, Inbred BALB C
Nitric Oxide / biosynthesis*
Transforming Growth Factor alpha / biosynthesis
Ureteral Obstruction / complications*
Reg. No./Substance:
0/Transforming Growth Factor alpha; 10102-43-9/Nitric Oxide; 148498-78-6/Adrenomedullin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  HAMLET Treatment Delays Bladder Cancer Development.
Next Document:  Photoselective Laser Vaporization Prostatectomy Versus Transurethral Prostate Resection: A Cost Anal...